TREATING ULCERATIVE COLITIS WITH MEDICINAL PLANTS AND INVESTIGATING THE QUALITY OF LIFE OF PATIENTS

Authors

  • Ibragimjon R. Askarov Andijan State University, Professor of the Department of Chemistry, Doctor of Chemistry, Honored Inventor of Uzbekistan, Chairman of the TABOBAT Academy of Uzbekistan
  • Khabibullo N. Kodirov Andijan State Medical Institute, Department of propedeutics of internal diseases, assistant

Keywords:

ulcerative colitis, SF-36, IBDQ-32

Abstract

The fact that many contemporary treatments for ulcerative colitis use medicinal plants in addition to basic medications explains the significance of diagnosing the condition in traditional medicine. This article also discusses how SF36 and IBDQ32 surveys can be used to examine the quality of life of patients.

References

Asqarov. I.R. "Tabobat qomusi".// T: Mumtoz

so’z. Toshkent. 2019 y, B. 3822. Asqarov I.R."Sirli tabobat".// T: Fan va

texnologiyalar nashriyot-matbaa uyi. Toshkent.

y. B. 821.

Asqarov. I.R. "Dalillarga asoslangan xalq

tabobati usullari". Toshkent-2023 y. 260-263

b.

Marshall J.K., Irvine E.J. Rectal corticosteroids

versus alternative treatments in ulcerative

colitis: a meta-analysis. Gut. 1997;40(6):775–

doi: 10.1136/gut.40.6.775.

Nguyen N.H., Fumery M., Dulai P.S. et al.

Comparative efficacy and tolerability of

pharmaco- logical agents for management of

mild to moderate ulcerative colitis: a

systematic review and network meta-analyses.

Lancet Gastroenterol Hepatol.

;3(11):742–753. doi: 10.1016/ S2468-

(18)30231-0.

Nikfar S., Rahimi R., Rezaie A., Abdollahi M. A

meta-analysis of the efficacy of sulfasalazine in

com- parison with 5-aminosalicylates in the

induction of improvement and maintenance of

remission in patients with ulcerative colitis. Dig

Dis Sci. 2009;54(6):1157–1170. doi:

1007/s10620-008-0481-x.

Ohkusa T., Kato K., Terao S. et al. Newly

developed antibiotic combination therapy for

ulcerativecoli- tis: a double-blind placebocontrolled multicenter trial. Am J

Gastroenterol. 2010;105(8):1820–1829. doi:

1038/ajg.2010.84.

Prantera C., Viscido A., Biancone L. et al. A

new oral delivery system for 5-ASA: preliminary clinical findings for MMx. Inflamm Bowel

Dis. 2005;11(5):421–427. doi: 10.1097/01.

mib.0000158386.25660.1e.

Yarur A.J., Rubin D.T. Therapeutic Drug

Monitoring of Anti-tumor Necrosis Factor

Agents in Pa- tients with Inflammatory Bowel

Diseases. Inflamm Bowel Dis.

;21(7):1709–1718. doi: 10.1097/

MIB.0000000000000380.

Zhang Y., Chen D., Wang F. et al. Comparison

of the efficiency of different enemas on

patients with distal ulcerative colitis. Cell Prolif.

;52(2):e12559. doi: 10.1111/cpr.12559.

Waljee AK, Joyce JC, Wren PA, Khan TM,

Higgins PDR. Patient reported symptoms

during an ulcerative colitis flare: a qualitative

focus group study. Eur J Gastroenterol

Hepatol. 2009;21(5):558- 564.

doi:10.1097/MEG.0b013e328326cacb

Wolfe BJ, Sirois FM. Beyond standard quality

of life measures: the subjective experiences of

living with inflammatory bowel disease. Qual

Life Res. 2008;17(6):877-886.

http://www.embase.com/search/res

Downloads

Published

2025-03-11

How to Cite

Ibragimjon R. Askarov, & Khabibullo N. Kodirov. (2025). TREATING ULCERATIVE COLITIS WITH MEDICINAL PLANTS AND INVESTIGATING THE QUALITY OF LIFE OF PATIENTS. World Bulletin of Public Health, 44, 24-27. Retrieved from https://scholarexpress.net/index.php/wbph/article/view/5031

Issue

Section

Articles